Walgreens Earache Drops recalled for microbial contamination of non-sterile product
Walgreens Earache Drops are recalled due to microbial contamination in the non-sterile product. Consumers should stop using the product and consult a healthcare provider if they experience any adverse effects.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: FDA Class II recall for microbial contamination in a non-sterile product intended for direct application to the ear canal. While no illnesses or injuries have been reported, the product presents a concrete risk of infection.
Plain-English summary
Walgreens Earache Drops, distributed by Walgreen Co., are being recalled due to microbial contamination in the non-sterile product. The recall involves 31,872 bottles of the 0.33 FL OZ (10 mL) formulation with Lot #G11639 and an expiration date of 09/24, distributed nationwide across the United States.
The product is manufactured by Grato Holdings, Inc. Consumers should stop using this product immediately and consult their healthcare provider if they have experienced any ear-related symptoms or adverse effects after using the recalled product.
The recalled product
- Product
- WALGREENS EARACHE DROPS (BELLADONNA LEAF, CALCIUM CARBONATE, CHAMOMILE, LYCOPODIUM CLAVATUM SPORE, ANEMONE PATENS, AND SULFUR)
- Brand
- WALGREENS EARACHE DROPS
- Manufacturer
- Grato Holdings, Inc.
- Category
- Drug
- Hazard
- microbial-contamination
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot #: G11639
- Exp. Date 09/24
UPCs (1)
- 0311917217123
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled for Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27